Sharon Begley March 8, 2016 The U.S. Patent and Trademark Office will begin proceeding that will determine the recipients of patents covering the use of CRISPR-Cas9 genome-editing technology. George Church (HMS) is mentioned. Read the full article
Could Lithium Explain — and Treat — Alzheimer’s Disease? August 6, 2025 Study: Lithium loss ignites Alzheimer’s, but lithium compound can reverse disease in mice
AI Distinguishes Glioblastoma From Look-Alike Cancers During Surgery September 29, 2025 New tool helps surgeons tell apart aggressive glioblastoma from other cancers in the brain
Deaths Rose in Emergency Rooms After Hospitals Were Acquired by Private Equity Firms September 22, 2025 Staffing, salary cuts offer likely explanation for increase compared to non-private-equity hospitals
